EADV 2023 Insights
EADV 2023 Insights: Drug Survival of IL-23 p19 Inhibitors Compared to Other Biologics for Psoriasis
By
EADV 2023 Insights
FEATURING
Zenas Yiu
By
EADV 2023 Insights
FEATURING
Zenas Yiu
Login to view comments.
Click here to Login
